I-21 Konstantinos Biliouris MatVPC: A User-friendly Matlab Tool for the Automatic Construction of Visual Predictive Checks and Quantified Visual Predictive Checks of Systems Pharmacology Models Wednesday 10:45-12:15 |
I-36 Theresa Cain Application of Simcyp’s R Library Package in Simulation and Prediction of Metoprolol Compliance Using a Single Plasma Concentration Sample Wednesday 10:45-12:15 |
I-37 Sophie Callies Dose projection and prediction of PK/PD response - a bench to bedside example for LY drug. Wednesday 10:45-12:15 |
I-44 Aziz Chaouch Approximate prediction percentiles for non-linear mixed effects models with continuous response Wednesday 10:45-12:15 |
I-47 Tina Checchio Mixed Effects Analysis of Non-compartmental Pharmacokinetic Parameters of Tofacitinib from 16 Phase 1 Studies. Wednesday 10:45-12:15 |
I-63 André Dallmann Development of a Physiologically-Based Pharmacokinetic Population Model for Pregnant Women Wednesday 10:45-12:15 |
I-74 Francesca Del Bene Modelling potential drug-drug interaction risks with a combined top-down/bottom-up approach Wednesday 10:45-12:15 |
II-06 Mark Sellors Reproducible Analysis Environments for Pharmacometric modelling and simulation. Wednesday 15:15-16:40 |
II-12 Yucheng Sheng Development of a New Mixed Poisson-Gaussian Model for Count Data from Rodent Brief-Access Taste Aversion Experiments Wednesday 15:15-16:40 |
II-21 Emmanouil G. Spanakis MyHealthAvatar platform: matching real life patients with the generated virtual profiles from in silico clinical trials Wednesday 15:15-16:40 |
II-27 Maciej Swat Standardized Output: flexible and tool-independent storage format of typical M&S results Wednesday 15:15-16:40 |
II-42 Moreno Ursino Incorporating pharmacokinetic information in phase I studies in small populations Wednesday 15:15-16:40 |
II-59 Thomas Wendl A whole-body physiologically-based pharmacokinetic (PBPK) Model for Itraconazole and its metabolite to predict dynamic drug-drug-interactions Wednesday 15:15-16:40 |
II-76 Rui Zhu Assessment of correlations between early and late efficacy endpoints to identify potential surrogacy relationships in non-Hodgkin lymphoma: a literature-based meta-analysis of 108 Phase II and Phase III studies Wednesday 15:15-16:40 |
III-05 Stephen Duffull An approximation to the solution of systems of nonlinear ordinary differential equations in pharmacokinetics-pharmacodynamics Thursday 10:20-11:45 |
III-25 Mario Gonzalez Sales inVentR: a new flexible, powerful and efficient R package for model drug development using NONMEM®. Thursday 10:20-11:45 |
III-28 Thaddeus Grasela Toward Progressive Reporting of Modeling and Simulation Results – Part 1: Analysis of KIWI™ Metadata Thursday 10:20-11:45 |
III-34 K. Melissa Hallow Interactive evaluation of dosing regimens for a novel anti-diabetic agent: a case-study in the application of RxODE Thursday 10:20-11:45 |
III-46 Moustafa M. A. Ibrahim Design of Phase I Studies based on Mechanism of Action of Anti-Diabetic Drugs; Assessing power, precision and accuracy in a simulation study of glucose tolerance tests Thursday 10:20-11:45 |
III-57 Amita Joshi Survey of methodologies for exposure-response analysis of oncology drugs approved in FDA from 2010 to 2013 Thursday 10:20-11:45 |
III-65 Ron Keizer New open source R libraries for simulation and visualization: “PKPDsim” and “vpc” Thursday 10:20-11:45 |
IV-10 Paolo Magni Evaluation of software tools for Bayesian estimation on population models with count and continuous data Thursday 15:20-16:40 |
IV-26 Jonathan Mochel Evaluating the dose-response relationship of furosemide on diuresis and renin-angiotensin aldosterone activation in dogs combining multiple comparisons and modeling techniques Thursday 15:20-16:40 |
IV-47 Lorenzo Pasotti Automatic translation of Bayesian pharmacometric models: the PharmML-to-WinBugs converter Thursday 15:20-16:40 |
IV-48 Devin Pastoor Standardizing and accelerating data analysis and pharmacometric workflow with the PKPDmisc R toolkit. Thursday 15:20-16:40 |
IV-65 Richard Pugh The Modeling & Simulation Workbench – Enabling Model-Based Decisions in Drug Development Thursday 15:20-16:40 |
IV-66 Didier Renard Modeling of pharmacokinetic data using nonlinear mixed-effects: a paradigm shift in veterinary pharmacology. A case study with the nonsteroidal anti-inflammatory robenacoxib in cats Thursday 15:20-16:40 |